Clinical trial
Efficacy and Tolerability of Ambroxol Lozenge 20 mf in Relieving Pain of Sore…
NCT00148499 · Boehringer Ingelheim, Industry · Completed
Key facts
| NCT number | NCT00148499 |
|---|---|
| Title | Efficacy and Tolerability of Ambroxol Lozenge 20 mf in Relieving Pain of Sore Throat in Pat. With Acute/Viralpharyngitis |
| Official title | Efficacy and Tolerability of Ambroxol Lozenge 20 mg in Relieving Pain of Sore Throat in Patients With Acute Viral Pharyngitis-A Randomised, Double-blind,Placebo- and Active-controlled Parallel Group Study |
| Lead sponsor | Boehringer Ingelheim, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Pharyngitis |
| Intervention type | Drug |
| Interventions | Ambroxol hydrochloride (Mucoangin?), benzocaine |
| Enrollment | 751 |
| Start date | Oct 1, 2005 |
| Primary completion | Jun 1, 2006 |
| Completion | Jun 1, 2006 |
| First posted | Sep 8, 2005 |
| Last update posted | Dec 28, 2017 |
| Countries | Romania, Ukraine |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: